BIM
VIVO

Bogle Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bogle Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,058
Closed -$584K – 346
2020
Q2 		$584K Sell
25,058
-131,870
-84% -$1.91M 0.1% 199
2020
Q1 		$1.32M Buy
+156,928
New +$1.32M 0.14% 156
2019
Q4 		– Sell
-155,816
Closed -$1.48M – 338
2019
Q3 		$1.48M Buy
155,816
+46,932
+43% +$495K 0.13% 153
2019
Q2 		$1.29M Sell
108,884
-27,010
-20% -$325K 0.1% 169
2019
Q1 		$2.39M Buy
+135,894
New +$2.26M 0.18% 136

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bogle Investment Management's VIVO Position: Q3 2020 in Review

Bogle Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 25,058 shares — an estimated $584K sold.

Bogle Investment Management first reported a position in VIVO in Q1 2019 and held it in 5 quarters. The position peaked at $2.39M in Q1 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Bogle Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Bogle Investment Management sold 25,058 Meridian Bioscience Inc shares in Q3 2020, an estimated $584K.
  • Bogle Investment Management first reported a position in Meridian Bioscience Inc in Q1 2019 and held it in 5 quarters.
  • Bogle Investment Management's Meridian Bioscience Inc position peaked at $2.39M in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.